)
Visual24 Oct 2025
The rise of Alphabet
2cureX (2CUREX) investor relations material
2cureX Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary21 Aug, 2025
Executive summary
H1 2025 marked by execution of a new strategy, validation of the direct-to-patient model, and expansion through partnerships and automation.
IndiTreat® accessed directly by patients in the UK, Sweden, and Germany, confirming market demand for precision oncology.
Strategic partnership with PreComb enables pharma collaborations and clinical trials in multiple cancer types.
AI-driven workflows and automation have improved operational efficiency and scalability.
Investor support remains strong, with ongoing capital and strategic input from key stakeholders.
Financial highlights
Net sales for H1 2025 reached 25 KSEK, compared to 0 KSEK in H1 2024.
Profit before tax improved to -1,951 KSEK from -9,560 KSEK year-over-year, reflecting reduced operational costs.
Cash and cash equivalents increased to 5,098 KSEK as of June 30, 2025, up from 3,130 KSEK a year earlier.
Equity ratio declined to 12% from 40% year-over-year.
Cash flow for H1 2025 was -42 KSEK, compared to 15 KSEK in H1 2024.
Outlook and guidance
Plans to scale the direct-to-patient model in the UK, Sweden, Denmark, and Germany.
Focus on delivering pharma collaborations via the PreComb partnership and supporting CE-IVDR regulatory milestones.
Continued integration of AI and automation to drive efficiency and growth.
Strengthening leadership team and exploring acquisitions to accelerate expansion.
Why did the equity ratio drop to 12% in H1 2025?
PreComb trials: What are the near-term milestones?
How does AI reduce overhead for scaling patient access?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next 2cureX earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
2cureX AB is a medtech company focused on improving cancer treatment through functional drug sensitivity testing. Its flagship product, IndiTreat, is an in vitro diagnostic (IVD) test that helps predict a cancer patient’s response to different drugs, enabling personalized treatment plans. IndiTreat is designed to assist in treating colorectal, ovarian, and pancreatic cancers, among others. The company is headuqartered in Copenhagen, Denmark, and its shares are listed on the Stockholm Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage